Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

nephrocystin-5 Inhibitors

Nephrocystin-5 inhibitors represent a class of chemical compounds that have been characterized for their ability to specifically interact with and inhibit the function of nephrocystin-5, a protein that plays a significant role in the structure and function of cilia in cells. Cilia are small, hair-like structures on the surface of cells that are involved in signaling pathways and movement, and they are essential for the proper functioning of various organs. Nephrocystin-5 is a part of a complex that localizes to the cilia and basal bodies of cells, and it is involved in maintaining the integrity of these structures. Inhibitors of nephrocystin-5 are molecules that can bind to this protein and reduce its activity, which can lead to changes in the function of cilia. The development of these inhibitors involves a detailed understanding of the nephrocystin-5 protein, including its structure, the nature of its interaction with other proteins in the cilium, and the specific domains that are crucial for its function. Techniques such as molecular docking and structure-based drug design are often employed to identify potential inhibitory compounds that fit into the active or binding sites of nephrocystin-5. The chemical synthesis of nephrocystin-5 inhibitors is a sophisticated process, demanding an intricate design that allows these molecules to bind selectively and with high affinity to the target protein. Such inhibitors may interact with the ATP-binding sites, substrate-binding sites, or allosteric sites on nephrocystin-5, aiming to alter its normal function. The specificity of these inhibitors is crucial, as off-target effects could lead to undesirable changes in cellular processes. The molecules often mimic the structure of the natural substrates or bind to key regions of the protein that are important for its function, thereby preventing the normal protein-protein interactions that are essential for ciliary function. These inhibitors could be designed to engage with nephrocystin-5 through a variety of non-covalent interactions, such as hydrogen bonding, van der Waals forces, and ionic interactions, ensuring a reversible yet effective inhibition.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

Cyclopamine inhibits the Hedgehog signaling pathway, which can impact the ciliary functions associated with nephrocystin-5.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, which can affect cell growth and proliferation, possibly interacting with nephrocystin-5's role in renal tubule cells.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor, which might impact the Akt signaling pathway, influencing cellular processes that nephrocystin-5 could be involved in.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is another PI3K inhibitor that can affect the Akt signaling pathway and potentially nephrocystin-5's function in renal cells.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$92.00
$260.00
42
(2)

Roscovitine is a CDK inhibitor that can affect cell cycle regulation, potentially influencing nephrocystin-5's role in cell division within the kidney.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 is a MEK inhibitor impacting the MAPK/ERK pathway, with potential indirect effects on nephrocystin-5 functions.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 is another MEK inhibitor, which may influence MAPK/ERK pathway, potentially affecting nephrocystin-5's function or expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor, which may alter stress response pathways and processes that nephrocystin-5 is involved with.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

ZD6474 (Vandetanib) inhibits VEGFR, which is involved in angiogenesis, and could indirectly affect renal function and nephrocystin-5 activity.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

SB-431542 is a TGF-beta receptor inhibitor, which could influence fibrotic processes in the kidney potentially related to nephrocystin-5's role.